Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Organon & CO (OGN)

Organon & CO (OGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,851,168
  • Shares Outstanding, K 254,330
  • Annual Sales, $ 6,304 M
  • Annual Income, $ 1,351 M
  • 60-Month Beta 0.47
  • Price/Sales 1.26
  • Price/Cash Flow 4.26
  • Price/Book N/A
Trade OGN with:

Options Overview Details

View History
  • Implied Volatility 29.55% ( -3.43%)
  • Historical Volatility 20.05%
  • IV Percentile 3%
  • IV Rank 9.62%
  • IV High 49.08% on 05/11/22
  • IV Low 27.47% on 08/16/22
  • Put/Call Vol Ratio 0.31
  • Today's Volume 72
  • Volume Avg (30-Day) 850
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 21,520
  • Open Int (30-Day) 15,709

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 1.14
  • Number of Estimates 4
  • High Estimate 1.30
  • Low Estimate 1.00
  • Prior Year 1.67
  • Growth Rate Est. (year over year) -31.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.49 +0.07%
on 08/18/22
33.20 -8.10%
on 07/26/22
-0.69 (-2.21%)
since 07/18/22
3-Month
30.49 +0.07%
on 08/18/22
39.09 -21.95%
on 05/26/22
-5.45 (-15.16%)
since 05/18/22
52-Week
28.50 +7.05%
on 12/03/21
39.47 -22.71%
on 03/02/22
-3.08 (-9.17%)
since 08/18/21

Most Recent Stories

More News
Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd)

Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced the U.S. Food and Drug Administration (FDA) has approved the citrate-free, high-concentration (100 mg/mL) formulation of HADLIMA™...

OGN : 30.50 (-1.20%)
New Strong Sell Stocks for August 8th

COWN, AUD, and OGN have been added to the Zacks Rank #5 (Strong Sell) List on August 8, 2022.

COWN : 38.66 (-0.08%)
AUD : 0.6693 (-1.57%)
OGN : 30.50 (-1.20%)
Organon (OGN) Surpasses Q2 Earnings and Revenue Estimates

Organon (OGN) delivered earnings and revenue surprises of 7.76% and 5.40%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

OGN : 30.50 (-1.20%)
SKIN : 13.01 (-2.40%)
Organon Reports Results for the Second Quarter Ended June 30, 2022

Organon (NYSE: OGN) (the “company”), today announced its results for the second quarter ended June 30, 2022.

OGN : 30.50 (-1.20%)
Analysts Estimate Viatris (VTRS) to Report a Decline in Earnings: What to Look Out for

Viatris (VTRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VTRS : 10.54 (-1.95%)
OGN : 30.50 (-1.20%)
Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate

Organon (NYSE: OGN), a global women’s healthcare company, and Cirqle Biomedical today announced they have entered into a research collaboration and exclusive license agreement for a novel investigational...

OGN : 30.50 (-1.20%)
Organon To Report Second Quarter Results and Host Conference Call on August 4, 2022

Organon (NYSE: OGN), a global women’s healthcare company will release its second quarter 2022 financial results on August 4, 2022, prior to the company’s webcast and conference call scheduled for 8:30...

OGN : 30.50 (-1.20%)
Cognizant Teams Up with Organon to Speed Delivery of Pharmaceutical Products and Improve Women's Healthcare

/PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced it has signed a new multi-year agreement with Organon (NYSE: OGN), a global women's health company, to...

CTSH : 69.02 (+0.17%)
OGN : 30.50 (-1.20%)
Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?

Smart Beta ETF report for RYH

RYH : 283.93 (-0.85%)
BMY : 73.65 (-1.22%)
CERN : 94.92 (-0.05%)
XLV : 131.92 (-0.92%)
VHT : 244.98 (-0.93%)
OGN : 30.50 (-1.20%)
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?

Sector ETF report for RYH

RYH : 283.93 (-0.85%)
BMY : 73.65 (-1.22%)
CERN : 94.92 (-0.05%)
XLV : 131.92 (-0.92%)
VHT : 244.98 (-0.93%)
OGN : 30.50 (-1.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J.

See More

Key Turning Points

3rd Resistance Point 31.65
2nd Resistance Point 31.39
1st Resistance Point 31.13
Last Price 30.50
1st Support Level 30.61
2nd Support Level 30.35
3rd Support Level 30.09

See More

52-Week High 39.47
Fibonacci 61.8% 35.28
Fibonacci 50% 33.99
Fibonacci 38.2% 32.69
Last Price 30.50
52-Week Low 28.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar